Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Feb 19, 2018 (9 years ago)

Vardenafil HCl

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

cGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Cause type: Stability / shelf life

The product degraded or failed stability testing before its labeled expiry. Heat, moisture or time can break the drug down into degradants or reduce potency. All stability / shelf life recalls.

What was recalled

Vardenafil HCl, USP (trihydrate), 500 GM Part # 330-05, Rx only, For Manufacturing, Repackaging and Processing for Rx and Research Only, Kalchem International, Inc. 224 South Main Street Lindsay, OK 73052 888-298-9905, NDC 60592-330-05

Affected NDC 60592-0330-05

Compare with the code on your package — it is the most precise check available.

Drug: Vardenafil

Recalling firm
Kalchem International, Inc.
NDC code
60592-330-05
Origin
OK, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0582-2018 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Vardenafil recalls

See all
Class II · Moderate risk

Vardenafil 20 mg Troche

Lack of Processing Controls (lack of assurance of conformity to specifications).

Terminated cGMP deviation MasterPharm LLC D-1442-2020
Class II · Moderate risk

Vardenafil HCl USP

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Terminated Stability / shelf life American Pharmaceutical Ingredients LLC NDC 58597-8575-2 D-0533-2018
Class II · Moderate risk

Vardenafil HCl Trihydrate active pharmaceutical ingredient…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-950-2015

Other stability / shelf life recalls from 2018

All stability / shelf life recalls
Class III · Low risk

Megestrol Acetate Oral Suspension

Failed Stability Specifications: Out-of-Specification results obtained for particle size distribution during stability testing.

Terminated Stability / shelf life Breckenridge Pharmaceutical, Inc. D-0279-2019
Class II · Moderate risk

Nystatin and Triamcinolone Acetonide Cream

Failed stability specifications - An out of specification result was observed for the test parameter : composition of Nystatin during stability testing.

Terminated Stability / shelf life Dr. Reddy's Laboratories, Inc. NDC 43598-431-44 D-0007-2019